Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 31:18:1059-1064.
doi: 10.2147/PPA.S445399. eCollection 2024.

Patient Involvement in the Design of an Innovative Clinical Study to Compare the Palatability of Anti-Hyperkalemia Medications

Henning Søndergaard  1
Affiliations

Patient Involvement in the Design of an Innovative Clinical Study to Compare the Palatability of Anti-Hyperkalemia Medications

Henning Søndergaard. Patient Prefer Adherence. .

Abstract

The inclusion of patient representatives as study consultants brings diverse perspectives, insights, and experiences to clinical trial design and execution, and their role in the clinical trial development process is being increasingly recognized and valued. The APPETIZE study evaluated the palatability of, and preference for, three potassium binders for treating hyperkalemia in patients with chronic kidney disease. A core aspect of the development of this study was the inclusion of a patient representative during the design stage. Here, I describe the process of patient involvement in the APPETIZE study design (ClinicalTrials.gov Identifier: NCT04566653), the resultant positive impacts, and key learnings. A patient with chronic kidney disease was invited to be a member of the APPETIZE trial design team. This patient representative attended study team meetings and provided invaluable input into protocol development, questionnaire selection, design of patient information sheets and consent forms, and primary manuscript structure. These critical insights resulted in an enhanced trial design and generation of high-quality, patient-relevant data. APPETIZE provides an excellent example of a patient preference study that relied on input from multiple stakeholder groups, including, most notably, the patients themselves. This approach may serve as a model for early and deep patient engagement in the design and interpretation of clinical trials.

Keywords: chronic kidney disease; clinical trials; hyperkalemia; patient representation.

PubMed Disclaimer

Conflict of interest statement

HS reports no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Patient involvement across the clinical trial lifecycle.
Figure 2
Figure 2
Stakeholder benefits from patient involvement in clinical trial design.
See this image and copyright information in PMC

References

    1. Yeoman G, Furlong P, Seres M, et al. Defining patient centricity with patients for patients and caregivers: a collaborative endeavour. BMJ Innov. 2017;3(2):76–83. doi:10.1136/bmjinnov-2016-000157 - DOI - PMC - PubMed
    1. Kaba R, Sooriakumaran P. The evolution of the doctor-patient relationship. Int J Surg. 2007;5(1):57–65. doi:10.1016/j.ijsu.2006.01.005 - DOI - PubMed
    1. Kilbride MK, Joffe S. The New Age of Patient Autonomy: Implications for the Patient-Physician Relationship. JAMA. 2018;320(19):1973–1974. doi:10.1001/jama.2018.14382 - DOI - PMC - PubMed
    1. Taylor K. Paternalism, participation and partnership - The evolution of patient centeredness in the consultation. Patient Educ Couns. 2009;74(2):150–155. doi:10.1016/j.pec.2008.08.017 - DOI - PubMed
    1. Edwards D, Best S. The Textbook of Health and Social Care. 1st ed. Sage Publications; 2020.

Associated data